drugset / Trial / NCT00628953

Adult Asthmatics and Acid Reflux

NCT00628953

Phase 2 Completed 1400 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of Nexium in the treatment of subjects with persistent asthma believed to have acid reflux as a contributory factor to control of their asthma.

Timeline

Start
2002-10
Primary completion
2004-04
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg

Indications